BeStock  
Stocks › Biotechnology › JANX

Janux Therapeutics JANX

US equityMarket cap rank #3470Biotechnology
$10.08 −$0.21 (-2.04%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $10.15 +0.69%
Open$10.11
Prev close$10.29
Day range$10.05 – $10.54
Volume1.11M
Market cap$616.73M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts12
Average target$30.80+205.6% vs. price
  • Buy 75%
  • Hold 17%
  • Sell 8%
Low $15.00Now $10.08Avg $30.80High $55.00

Recent rating changes

The last 20 actions on file set price targets from $15.00 to $55.00, averaging $31.88.

DateFirmRatingTarget
12 Nov 2026 Wolfe Research HOLD –
12 Nov 2026 H.C. Wainwright BUY $45.00
10 Nov 2026 UBS HOLD $15.00
10 Nov 2026 Piper Sandler BUY $26.00
10 Nov 2026 Stifel BUY $34.00
9 Nov 2026 William Blair BUY –
6 Nov 2026 JonesTrading BUY $28.00
6 Nov 2026 Piper Sandler BUY $26.00
6 Nov 2026 BofA Securities BUY $23.00
6 Nov 2026 Truist Financial BUY $27.00
6 Nov 2026 Wedbush BUY $40.00
6 Nov 2026 Stifel BUY $34.00
6 Nov 2026 Barclays SELL $15.00
5 Nov 2026 Guggenheim BUY $55.00
19 Oct 2026 H.C. Wainwright BUY $45.00
15 Oct 2026 Truist Financial BUY $26.00
1 Oct 2026 H.C. Wainwright BUY $45.00
24 Aug 2026 Wolfe Research BUY $23.00
13 Aug 2026 William Blair BUY –
11 Aug 2026 Stifel BUY $35.00

Discussion

No comments yet — be the first to weigh in on JANX.

Sign in to join the discussion.

Scroll to Top